Related Experiment Videos
[Growth hormone therapy in adults]
1Bereich Endokrinologie und Diabetologie, Klinikum der Philipps-Universität Marburg. Kannp@med.uni-marburg.de
Der Internist
|June 2, 2005
Summary
Growth hormone (GH) substitution is effective for adult hypopituitarism, supported by strong evidence. However, its use in healthy elderly individuals or for sports doping lacks sufficient research and raises safety concerns.
Area of Science:
- Endocrinology
- Pharmacology
Context:
- Growth hormone (GH) deficiency in adults results from organic hypopituitarism.
- GH substitution therapy is an established treatment for this condition.
Purpose:
- To evaluate the efficacy and safety of growth hormone substitution in adult hypopituitarism.
- To contrast this with the unproven and potentially unsafe uses of GH in healthy elderly individuals and for sports doping.
Summary:
- Randomized controlled trials demonstrate the positive influence of GH substitution on numerous parameters in patients with hypopituitarism.
- This therapy is scientifically founded and approved by European Union authorities.
- The use of GH in healthy elderly persons and for sports doping is not well-researched, with significant safety, ethical, and economic concerns.
Impact:
- Confirms the established role of GH therapy in treating adult hypopituitarism.
- Highlights the critical lack of evidence and potential risks associated with off-label GH use.
- Informs clinical practice and regulatory perspectives on GH pharmacotherapy.